Solving Major Bottlenecks in Genetic Medicine & SynBio w DNA Synthesis Innovation
SOURCE: Big4Bio
APR 15, 2024
In this episode of Big4Bio's Company to Watch, Danny Levine interviews Matthew Hill, Ph.D., founder and CEO of Elegen, on the next big innovation in manufacturing DNA, which bypasses synthetic DNA bottlenecks to accelerate upstream and downstream workflows.